CD200+ fibroblasts form a pro-resolving mesenchymal network in arthritis
Nature Immunology · 2024-04 · 25 (4) · 682-692
DOI: 10.1038/s41590-024-01774-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nature Immunology, online erschienen am 23.02.2024. Verfasst von Simon Rauber und 37 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erla…. Hauptthemen laut MEDLINE: Immunity, Innate, Arthritis. Die Arbeit wurde bisher 84-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft (German Research Foundation), EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - E…, Innovative Medicines Initiative (IMI).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
- Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
- Department of Nuclear Medicine, Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
- Department of Industrial Engineering and Health, Technical University Amberg-Weiden, Institute of Medical Engineering, Weiden, Germany.
- Institute of Radiology, Friedrich-Alexander-University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
- Rheumatology Research Group, Institute for Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Queen Elizabeth Hospital, Birmingham, UK.
Förderung
- Deutsche Forschungsgemeinschaft (German Research Foundation)
- EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - E…
- Innovative Medicines Initiative (IMI)
- Bundesministerium für Bildung, Wissenschaft, Forschung und Technologie (Federal Ministry for Education, Science, Research and Technology)
Zitieren
APA
Rauber, S., Mohammadian, H., Schmidkonz, C., Atzinger, A., Soare, A., Treutlein, C., Kemble, S., Mahony, C. B., Geisthoff, M., Angeli, M. R., Raimondo, M. G., Xu, C., Yang, K. T., Lu, L., Labinsky, H., Saad, M. S. A., Gwellem, C. A., Chang, J., Huang, K., …, & Ramming, A. (2024). CD200+ fibroblasts form a pro-resolving mesenchymal network in arthritis. Nature Immunology, 25(4), 682-692. https://doi.org/10.1038/s41590-024-01774-4
Vancouver
Rauber S, Mohammadian H, Schmidkonz C, Atzinger A, Soare A, Treutlein C, et al. CD200+ fibroblasts form a pro-resolving mesenchymal network in arthritis. Nature Immunology. 2024;25(4):682-692. doi:10.1038/s41590-024-01774-4
BibTeX
@article{Rauber2024,
author = {Rauber, Simon and Mohammadian, Hashem and Schmidkonz, Christian and Atzinger, Armin and Soare, Alina and Treutlein, Christoph and Kemble, Samuel and Mahony, Christopher B and Geisthoff, Manuel and Angeli, Mario R and Raimondo, Maria G and Xu, Cong and Yang, Kai-Ting and Lu, Le and Labinsky, Hannah and Saad, Mina S A and Gwellem, Charles A and Chang, Jiyang and Huang, Kaiyue and Kampylafka, Eleni and Knitza, Johannes and Bilyy, Rostyslav and Distler, Jörg H W and Hanlon, Megan M and Fearon, Ursula and Veale, Douglas J and Roemer, Frank W and Bäuerle, Tobias and Maric, Hans M and Maschauer, Simone and Ekici, Arif B and Buckley, Christopher D and Croft, Adam P and Kuwert, Torsten and Prante, Olaf and Cañete, Juan D and Schett, Georg and Ramming, Andreas},
title = {CD200+ fibroblasts form a pro-resolving mesenchymal network in arthritis},
journal = {Nature Immunology},
year = {2024},
volume = {25},
number = {4},
pages = {682--692},
doi = {10.1038/s41590-024-01774-4}
}
EUVIMED